|
Issue |
Title |
|
No 1 (2023) |
The NGS panel for genetic testing in cardiology: from the evaluation of disease risk to pharmacogenetics |
Abstract
PDF (Rus)
|
V. V. Miroshnikova, S. N. Pchelina, M. Yu. Donnikov, A. S. Vorobyev, V. V. Tsay, L. V. Kovalenko, O. S. Glotov |
|
No 1 (2021) |
Pharmacogenetics of antiviral agents for the treatment of COVID-19 |
Abstract
PDF (Rus)
|
I. I. Temirbulatov, A. V. Kryukov, D. A. Sychev |
|
No 1 (2020) |
Promising areas of research on the pharmacogenetics of dabigatran etexilate |
Abstract
PDF (Rus)
|
A. V. Savinova, N. A. Shnayder, M. M. Petrova, R. F. Nasyrova |
|
No 1 (2019) |
Pharmacogenetics of pharmacodynamic targets of statin action |
Abstract
PDF (Rus)
|
M. V. Leonova |
|
No 1 (2019) |
Genetic prerequisites for reducing serum retinol concentration |
Abstract
PDF (Rus)
|
E. M. Zelenskaya, G. I. Lifshits |
|
1 - 5 of 5 Items |
|